Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

International Journal of Antimicrobial Agents

Volumn 25, Issue 5, 2005, Pages 380-384

  Sader, Helio S ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acinetobacter spp.; Ampicillin sulbactam; Cefepime; P. aeruginosa; Resistance; Synergy

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE;

EID: 17644393475     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.01.011     Document Type: Article

References (17)

1. O. Mimoz, S. Leotard, and A. Jacolot Efficacies of imipenem, meropenem, cefepime and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing β-lactamase-producing strain of Enterobacter cloacae Antimicrob Agents Chemother 44 2000 885 890
2. M.A. Toleman, A.M. Simm, and T.A. Murphy Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Program J Antimicrob Chemother 50 2002 673 679
3. P.G. Higgins, H. Wisplinghoff, D. Stefanik, and H. Seifert In vitro activities of the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with β-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains Antimicrob Agents Chemother 48 2004 1586 1592
4. C. Urban, E. Go, N. Mariano, and J.J. Rahal Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and imipenem-susceptible Acinetobacter baumannii FEMS Microbiol Lett 125 1995 193 197
5. R.N. Jones, L.M. Deshpande, T.R. Fritsche, and H.S. Sader Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA; 1999-2003) Diagn Microbiol Infect Dis 49 2004 211 216
6. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A6 2003 NCCLS Wayne, PA
7. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. Supplemental tables M100-S15 2005 NCCLS Wayne, PA
8. G.M. Eliopoulos, and RC. Moellering Jr. Antimicrobial combinations V. Lorian Antibiotics in laboratory medicine 4th ed. 1996 Williams & Wilkins Baltimore, MD 330 396
9. J. Moody Susceptibility tests to evaluate synergism H.D. Isenberg Clinical microbiology procedures handbook 2004 ASM Press Washington, DC 5.12.1 5.12.23
10. W. Song, H.J. Woo, J.S. Kim, and K.M. Lee In vitro activity of β-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa Internat J Antimicrob Agents 21 2003 8 12
11. C. Urban, S. Segal-Maurer, and J.J. Rahal Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii Clin Infect Dis 36 2003 1268 1274
12. J.P. Ouderkirk, J.A. Nord, G.S. Turett, and J.W. Kislak Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant Gram-negative bacteria Antimicrob Agents Chemother 47 2003 2659 2662
13. A.S. Levin, A.A. Barone, and J. Penco Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infect Dis 28 1999 1008 1011
14. M.E. Sobieszczyk, E.Y. Furuya, and C.M. Hay Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections J Antimicrob Chemother 54 2004 566 569
15. P.D. Lister, W.E. Sanders Jr., and C.C. Sanders Cefepime-aztreonam: a unique double β-lactam combination for Pseudomonas aeruginosa Antimicrob Agents Chemother 42 1998 1610 1619
16. M.D. Appleman, H. Belzberg, and D.M. Citron In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak Antimicrob Agents Chemother 44 2000 1035 1040
17. A.S. Levin Treatment of Acinetobacter spp. infections Expert Opin Pharmacother 4 2003 1289 1296